Correlates of hazardous drinking among Veterans with and without hepatitis C

Megan Oser*, Michael Cucciare, John McKellar, Kenneth Weingardt

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Hazardous drinking is a major barrier to antiviral treatment eligibility among hepatitis C (HCV) patients. We evaluated differences in substance-related coping, drinking-related consequences, and importance and confidence in ability to change alcohol use among hazardous drinkers with and without HCV (N = 554; 93.5% male). We examined group differences between HCV+ patients (n = 43) and their negative HCV counterparts (n = 511). Results indicate a higher percentage of HCV+ patients report using substances to cope with possible symptoms of PTSD (P<.05) and depression (P<.01), and endorse more lifetime drinking-related negative consequences than HCV patients (P<.01). Furthermore, HCV+ patients place greater importance on changing alcohol use (P<.01) but report less confidence in their ability to change (P<.01). Use of brief assessment and feedback with skills-based interventions to decrease alcohol use may be well-received by HCV+ patients.

Original languageEnglish (US)
Pages (from-to)634-641
Number of pages8
JournalJournal of Behavioral Medicine
Volume35
Issue number6
DOIs
StatePublished - Dec 2012

Funding

Acknowledgments This research was partially supported by the Department of Veteran Affairs, Office of Academic Affiliations’ Post Doctoral Fellowship Program in Health Services Research to Dr. Oser. The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.

Keywords

  • Alcohol use
  • Coping
  • Hazardous drinking
  • Hepatitis C
  • Mental health symptoms
  • Veterans

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • General Psychology

Fingerprint

Dive into the research topics of 'Correlates of hazardous drinking among Veterans with and without hepatitis C'. Together they form a unique fingerprint.

Cite this